Boston Scientific Corp - Net Worth and Insider Trading
Boston Scientific Corp Net Worth
The estimated net worth of Boston Scientific Corp is at least $218 Million dollars as of 2024-05-28. Boston Scientific Corp is the 10% Owner of LivaNova PLC and owns about 3,435,140 shares of LivaNova PLC (LIVN) stock worth over $206 Million. Boston Scientific Corp is also the 10% Owner of Pulmonx Corp and owns about 1,488,106 shares of Pulmonx Corp (LUNG) stock worth over $12 Million. Details can be seen in Boston Scientific Corp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Boston Scientific Corp has not made any transactions after 2021-07-13 and currently still holds the listed stock(s).
Transaction Summary of Boston Scientific Corp
Boston Scientific Corp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Boston Scientific Corp owns 3 companies in total, including Pulmonx Corp (LUNG) , Sycamore Entertainment Group Inc (SEGI) , and VIA Pharmaceuticals Inc (VIAP) .
Click here to see the complete history of Boston Scientific Corp’s form 4 insider trades.
Insider Ownership Summary of Boston Scientific Corp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LUNG | Pulmonx Corp | 2021-07-13 | 10 percent owner |
| SEGI | Sycamore Entertainment Group Inc | 2008-09-17 | 10 percent owner |
| VIAP | VIA Pharmaceuticals Inc | 2003-07-30 | 10 percent owner |
Boston Scientific Corp Latest Holdings Summary
Boston Scientific Corp currently owns a total of 2 stocks. Among these stocks, Boston Scientific Corp owns 3,435,140 shares of LivaNova PLC (LIVN) as of March 29, 2005, with a value of $206 Million and a weighting of 94.54%. Boston Scientific Corp also owns 1,488,106 shares of Pulmonx Corp (LUNG) as of July 13, 2021, with a value of $12 Million and a weighting of 5.46%.
Latest Holdings of Boston Scientific Corp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LIVN | LivaNova PLC | 2005-03-29 | 3,435,140 | 60.04 | 206,245,806 |
| LUNG | Pulmonx Corp | 2021-07-13 | 1,488,106 | 8.01 | 11,919,729 |
Holding Weightings of Boston Scientific Corp
Boston Scientific Corp Form 4 Trading Tracker
According to the SEC Form 4 filings, Boston Scientific Corp has made a total of 0 transactions in LivaNova PLC (LIVN) over the past 5 years. The most-recent trade in LivaNova PLC is the acquisition of 75,140 shares on March 29, 2005, which cost Boston Scientific Corp around $3 Million.
According to the SEC Form 4 filings, Boston Scientific Corp has made a total of 3 transactions in Pulmonx Corp (LUNG) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Pulmonx Corp is the sale of 2,500,000 shares on July 13, 2021, which brought Boston Scientific Corp around $94 Million.
Insider Trading History of Boston Scientific Corp
- 1
Boston Scientific Corp Trading Performance
GuruFocus tracks the stock performance after each of Boston Scientific Corp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Boston Scientific Corp is 12.44%. GuruFocus also compares Boston Scientific Corp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Boston Scientific Corp within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Boston Scientific Corp's insider trading performs compared to the benchmark.
Performance of Boston Scientific Corp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.32 | | | | | |
| Relative Return to S&P 500(%) | -2.63 | | | | | |
Boston Scientific Corp Ownership Network
Boston Scientific Corp Owned Company Details
What does Pulmonx Corp do?
Who are the key executives at Pulmonx Corp?
Boston Scientific Corp is the 10 percent owner of Pulmonx Corp. Other key executives at Pulmonx Corp include Chief Commercial Officer Geoffrey Beran Rose , Interim CFO John Mckune , and General Counsel David Aaron Lehman .
Pulmonx Corp (LUNG) Insider Trades Summary
Over the past 18 months, Boston Scientific Corp made no insider transaction in Pulmonx Corp (LUNG). Other recent insider transactions involving Pulmonx Corp (LUNG) include a net sale of 25,754 shares made by Geoffrey Beran Rose , a net sale of 98,216 shares made by French Glendon E. Iii , and a net sale of 18,041 shares made by David Aaron Lehman .
In summary, during the past 3 months, insiders sold 19,032 shares of Pulmonx Corp (LUNG) in total and bought 0 shares, with a net sale of 19,032 shares. During the past 18 months, 154,805 shares of Pulmonx Corp (LUNG) were sold and 1,700 shares were bought by its insiders, resulting in a net sale of 153,105 shares.
Pulmonx Corp (LUNG)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pulmonx Corp Insider Transactions
Boston Scientific Corp Mailing Address
Above is the net worth, insider trading, and ownership report for Boston Scientific Corp. You might contact Boston Scientific Corp via mailing address: 300 Boston Scientific Way, Marlborough Ma 01752-1234.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
